MAPT and Alzheimer disease: The role of CK1 as a potential kinase phosphorylating tau has become of particular interest, because it has been reported that levels of CK1δ were elevated by a factor of 30 in the hippocampus in the brain of AD patients compared with equivalent controls (Ghoshal et al., 1999).